AtriCure Inc (ATRC)
35.68
-0.35
(-0.97%)
USD |
NASDAQ |
Nov 21, 16:00
35.68
0.00 (0.00%)
After-Hours: 20:00
AtriCure Revenue (Quarterly): 115.91M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 115.91M |
| June 30, 2024 | 116.27M |
| March 31, 2024 | 108.85M |
| December 31, 2023 | 106.54M |
| September 30, 2023 | 98.29M |
| June 30, 2023 | 100.92M |
| March 31, 2023 | 93.49M |
| December 31, 2022 | 88.03M |
| September 30, 2022 | 83.25M |
| June 30, 2022 | 84.53M |
| March 31, 2022 | 74.58M |
| December 31, 2021 | 73.22M |
| September 30, 2021 | 70.46M |
| June 30, 2021 | 71.38M |
| March 31, 2021 | 59.28M |
| December 31, 2020 | 57.72M |
| September 30, 2020 | 54.76M |
| June 30, 2020 | 40.82M |
| March 31, 2020 | 53.22M |
| December 31, 2019 | 61.32M |
| September 30, 2019 | 56.61M |
| June 30, 2019 | 58.91M |
| March 31, 2019 | 53.97M |
| December 31, 2018 | 52.89M |
| September 30, 2018 | 49.94M |
| Date | Value |
|---|---|
| June 30, 2018 | 51.80M |
| March 31, 2018 | 46.99M |
| December 31, 2017 | 46.06M |
| September 30, 2017 | 42.15M |
| June 30, 2017 | 45.23M |
| March 31, 2017 | 41.27M |
| December 31, 2016 | 41.16M |
| September 30, 2016 | 38.34M |
| June 30, 2016 | 39.67M |
| March 31, 2016 | 35.94M |
| December 31, 2015 | 35.86M |
| September 30, 2015 | 31.42M |
| June 30, 2015 | 32.58M |
| March 31, 2015 | 29.89M |
| December 31, 2014 | 29.42M |
| September 30, 2014 | 26.68M |
| June 30, 2014 | 26.51M |
| March 31, 2014 | 24.85M |
| December 31, 2013 | 21.88M |
| September 30, 2013 | 20.15M |
| June 30, 2013 | 20.43M |
| March 31, 2013 | 19.43M |
| December 31, 2012 | 18.36M |
| September 30, 2012 | 16.14M |
| June 30, 2012 | 18.27M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
40.82M
Minimum
Jun 2020
116.27M
Maximum
Jun 2024
80.64M
Average
78.91M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.35M |
| Xtant Medical Holdings Inc | 27.94M |
| Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.853M |
| Total Expenses (Quarterly) | 123.32M |
| EPS Diluted (Quarterly) | -0.17 |
| Enterprise Value | 1.671B |
| Gross Profit Margin (Quarterly) | 74.88% |
| Profit Margin (Quarterly) | -6.78% |
| Earnings Yield | -2.33% |
| Normalized Earnings Yield | -2.262 |